Karlijn Verkerk
6PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 01, 2025
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn
|Sep 25, 2025
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.Iris L Mimpen, Thomas W Battaglia, Miguel Parra-Martinez
|Oct 01, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.Karlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn
|Aug 19, 2023
Interrater agreement in classifying infections during extracorporeal membrane oxygenation.Karlijn Verkerk, Lara Ca Pladet, Christiaan L Meuwese
|Sep 20, 2022
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.Karlijn Verkerk, Hans-Martin Otten, Alwin D R Huitema
Pageof 1
Frequent Collaborators
4 joint publications
Vincent van der Noort
4 joint publications
Hans Gelderblom
4 joint publications
Emile E Voest
3 joint publications
Laurien J Zeverijn
3 joint publications
Birgit S Geurts
2 joint publications
Hans Timmer
2 joint publications
Maud A van Maren
2 joint publications
Anne M L Jansen
2 joint publications
Ilse A C Spiekman
2 joint publications
Paul Roepman
